跳至主要内容
临床试验/IRCT20140810018745N12
IRCT20140810018745N12招募中2 期

Effects of 5-aminolevulinic acid on the treatment response and the quality of life in the patients with glioblastoma

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Patients with written informed consent; randomized; patients with glioblastoma multiforme; patients with KPS above 70 or ECOG 0-1; patients with 30-70 years

排除标准

  • Patients with renal, cardiac, and hepatic problems; Patients with intestinal obstruction; Patients with GFR less than 30; Patients with immunodeficiency such as AIDS and hepatitis; Patients with low white blood cell (less of 1000).

研究者

相似试验